Wu Xi App Tec Co., Ltd. Lyell Immunopharma, Inc. Transaction History
Wu Xi App Tec Co., Ltd.
- $19 Billion
- Q3 2024
A detailed history of Wu Xi App Tec Co., Ltd. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Wu Xi App Tec Co., Ltd. holds 7,390,710 shares of LYEL stock, worth $125 Million. This represents 53.56% of its overall portfolio holdings.
Number of Shares
7,390,710
Previous 7,682,156
3.79%
Holding current value
$125 Million
Previous $11.1 Billion
8.44%
% of portfolio
53.56%
Previous 47.74%
Shares
3 transactions
Others Institutions Holding LYEL
# of Institutions
9Shares Held
37.4MCall Options Held
0Put Options Held
0-
Apoletto LTD Washington, DC15.1MShares$256 Million42.56% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$228 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL641KShares$10.9 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA595KShares$10.1 Million1.69% of portfolio
-
Credit Suisse Ag Zurich, V8123KShares$2.09 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $4.2B
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...